Cargando…

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

BACKGROUND: New immunotherapeutic strategies based on predictors are urgently needed. Toll-like receptor adaptor interacting with SLC15A4 on the lysosome (TASL) was recently confirmed to fulfill an important role in the innate immune response. However, whether TASL is involved in tumor development a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huanyu, Sun, Xiaoyu, Zhao, Yanyun, Zhang, Changzhu, Jiang, Kai, Ren, Jie, Xing, Lijuan, He, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251564/ https://www.ncbi.nlm.nih.gov/pubmed/37296415 http://dx.doi.org/10.1186/s12885-023-11015-w

Ejemplares similares

Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
por: Li, Qiao, et al.
Publicado: (2023)

Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1
por: Custódio, Tânia F., et al.
Publicado: (2023)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling
por: Chen, Xudong, et al.
Publicado: (2023)

Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
por: Shen, Chong, et al.
Publicado: (2023)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
por: Cheng, Lang, et al.
Publicado: (2023)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9
por: Heinz, Leonhard X., et al.
Publicado: (2020)

A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity
por: Boeszoermenyi, Andras, et al.
Publicado: (2023)

Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?
por: Gao, Xiao-Peng, et al.
Publicado: (2021)

Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker
por: Fang, Tao, et al.
Publicado: (2022)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
por: Ning, Yijie, et al.
Publicado: (2023)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
por: Huang, Tingting, et al.
Publicado: (2022)

Role of SERCA3 in the Prognosis and Immune Function in Pan-Cancer
por: Li, Jiajia, et al.
Publicado: (2022)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
por: Jia, Yan, et al.
Publicado: (2021)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

Withdrawal notice to: “Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data” [Heliyon 9, (2023) 16897]
por: Shen, Chong, et al.
Publicado: (2023)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis
por: Zhang, Zerui, et al.
Publicado: (2022)

CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis
por: Li, Yang, et al.
Publicado: (2022)

Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
por: Qiao, Han, et al.
Publicado: (2022)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
por: Hu, Pengbo, et al.
Publicado: (2022)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
por: Li, Guangyao, et al.
Publicado: (2022)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis
por: Bao, Lingling, et al.
Publicado: (2021)

CLP1 is a Prognosis-Related Biomarker and Correlates With Immune Infiltrates in Rheumatoid Arthritis
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mtu37t4r5td0oup9gav07osee3